Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 80 | 87 | +7 |
| Shares | 35.0M | 39.5M | +4.53M (+13.0%) |
| Value | $70.7M | $47.2M | −$23.5M (−33.2%) |
New holders (21)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 2,000,025 | $2.38M | 0.00% |
| Balyasny Asset Management LLC | 851,325 | $1.01M | 0.00% |
| Ameriprise Financial Inc | 666,666 | $793.3K | 0.00% |
| Seven Fleet Capital Management LP | 333,333 | $396.7K | 0.12% |
| Boothbay Fund Management, LLC | 168,675 | $200.7K | 0.00% |
| Simplex Trading, LLC | 149,291 | $177.7K | 0.01% |
| Quadrature Capital Ltd | 149,105 | $177.4K | 0.00% |
| Renaissance Technologies LLC | 129,705 | $154.3K | 0.00% |
| HRT Financial LP | 62,256 | $74.0K | 0.00% |
| Welch & Forbes LLC | 25,000 | $29.8K | 0.00% |
| AE Wealth Management LLC | 15,000 | $17.9K | 0.00% |
| Vision Retirement, LLC | 15,000 | $17.9K | 0.01% |
| Exit Wealth Advisors, LLC. | 15,000 | $17.9K | 0.01% |
| Capital Performance Advisors LLP | 14,756 | $17.6K | 0.00% |
| IMC-Chicago, LLC | 10,943 | $13.0K | 0.00% |
| Wealthspire Advisors, LLC | 10,629 | $12.6K | 0.00% |
| HighTower Advisors, LLC | 10,000 | $11.9K | 0.00% |
| CWM, LLC | 10,000 | $11.9K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1,729 | $2.06K | 0.00% |
| The PNC Financial Services Group, Inc. | 1,000 | $1.19K | 0.00% |
| Russell Investments Group, Ltd. | 125 | $149 | 0.00% |
Sold out (14)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 2,810,037 | $5.68M |
| Stonepine Capital Management, LLC | 662,666 | $1.34M |
| Two Sigma Advisers, LP | 619,592 | $1.25M |
| Nomura Holdings Inc | 225,000 | $454.5K |
| Graham Capital Management, L.P. | 133,620 | $269.9K |
| Cascades Capital Asset Management, LLC | 77,510 | $156.6K |
| Engineers Gate Manager LP | 59,053 | $119.3K |
| Qube Research & Technologies Ltd | 34,596 | $69.9K |
| Citigroup Inc | 33,858 | $68.4K |
| Scientech Research LLC | 30,124 | $60.9K |
| Quantbot Technologies LP | 18,990 | $38.4K |
| AQR Capital Management LLC | 10,000 | $20.2K |
| SRS Capital Advisors, Inc. | 1,591 | $3.21K |
| Bank of America Corp | 841 | $1.70K |